Peter W Hunt

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
    Peter W Hunt
    Positive Health Program, San Francisco General Hospital, and San Francisco Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Infect Dis 187:1534-43. 2003
  2. pmc Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients
    Priscilla Y Hsue
    Division of Cardiology, Positive Health Program of the Department of Medicine, San Francisco General Hospital, University of California San Francisco, 1001 Potrero Avenue, San Francisco, CA 94110, USA
    AIDS 23:2021-7. 2009
  3. ncbi request reprint The independent effect of drug resistance on T cell activation in HIV infection
    Peter W Hunt
    Positive Health Program, San Francisco General Hospital, University of California, San Francisco, California 94110, USA
    AIDS 20:691-9. 2006
  4. pmc Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy
    Peter W Hunt
    Positive Health Program, San Francisco General Hospital, Bldg 80, Ward 84, 995 Potrero Ave, San Francisco, CA 94110, USA
    J Infect Dis 197:126-33. 2008
  5. pmc Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals
    Hiroyu Hatano
    Department of Medicine, University of California, San Francisco, California, USA
    AIDS 24:2535-9. 2010
  6. ncbi request reprint Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses
    Priscilla Y Hsue
    Divisions of Cardiology, San Francisco General Hospital, University of California, San Francisco, USA
    AIDS 20:2275-83. 2006
  7. pmc Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis
    Priscilla Y Hsue
    Division of Cardiology, San Francisco General Hospital, San Francisco, California 94110, USA
    AIDS 23:1059-67. 2009
  8. pmc Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells
    Hiroyu Hatano
    Department of Medicine, San Francisco General Hospital, 995 Potrero Ave, San Francisco, CA 94110, USA
    J Infect Dis 208:50-6. 2013
  9. ncbi request reprint Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia
    Peter W Hunt
    Positive Health Program, San Francisco General Hospital, San Francisco, CA 94110, USA
    J Infect Dis 194:926-30. 2006
  10. pmc A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response
    Hiroyu Hatano
    University of California, San Francisco, USA
    J Infect Dis 203:960-8. 2011

Detail Information

Publications47

  1. ncbi request reprint T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
    Peter W Hunt
    Positive Health Program, San Francisco General Hospital, and San Francisco Veterans Affairs Medical Center, San Francisco, California 94121, USA
    J Infect Dis 187:1534-43. 2003
    ..Interventions that directly target T cell activation or the determinants of activation may prove to be useful adjuvants to antiretroviral therapy...
  2. pmc Association of abacavir and impaired endothelial function in treated and suppressed HIV-infected patients
    Priscilla Y Hsue
    Division of Cardiology, Positive Health Program of the Department of Medicine, San Francisco General Hospital, University of California San Francisco, 1001 Potrero Avenue, San Francisco, CA 94110, USA
    AIDS 23:2021-7. 2009
    ..As endothelial dysfunction is central to the pathogenesis of atherosclerosis, we tested the hypothesis that current treatment with abacavir is associated with impaired endothelial function...
  3. ncbi request reprint The independent effect of drug resistance on T cell activation in HIV infection
    Peter W Hunt
    Positive Health Program, San Francisco General Hospital, University of California, San Francisco, California 94110, USA
    AIDS 20:691-9. 2006
    ....
  4. pmc Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy
    Peter W Hunt
    Positive Health Program, San Francisco General Hospital, Bldg 80, Ward 84, 995 Potrero Ave, San Francisco, CA 94110, USA
    J Infect Dis 197:126-33. 2008
    ....
  5. pmc Evidence of persistent low-level viremia in long-term HAART-suppressed, HIV-infected individuals
    Hiroyu Hatano
    Department of Medicine, University of California, San Francisco, California, USA
    AIDS 24:2535-9. 2010
    ..HAART can effectively reduce plasma HIV RNA levels to below the level of detection in most HIV-infected patients. The degree to which residual low-level viremia persists during HAART remains unclear...
  6. ncbi request reprint Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses
    Priscilla Y Hsue
    Divisions of Cardiology, San Francisco General Hospital, University of California, San Francisco, USA
    AIDS 20:2275-83. 2006
    ....
  7. pmc Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis
    Priscilla Y Hsue
    Division of Cardiology, San Francisco General Hospital, San Francisco, California 94110, USA
    AIDS 23:1059-67. 2009
    ....
  8. pmc Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells
    Hiroyu Hatano
    Department of Medicine, San Francisco General Hospital, 995 Potrero Ave, San Francisco, CA 94110, USA
    J Infect Dis 208:50-6. 2013
    ..Studies aimed at defining the association between host immune responses and human immunodeficiency virus (HIV) persistence during therapy are necessary to develop new strategies for cure...
  9. ncbi request reprint Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia
    Peter W Hunt
    Positive Health Program, San Francisco General Hospital, San Francisco, CA 94110, USA
    J Infect Dis 194:926-30. 2006
    ..CCR5 inhibitors may thus be best strategically used before salvage therapy and before significant CD4 + T cell depletion...
  10. pmc A randomized, controlled trial of raltegravir intensification in antiretroviral-treated, HIV-infected patients with a suboptimal CD4+ T cell response
    Hiroyu Hatano
    University of California, San Francisco, USA
    J Infect Dis 203:960-8. 2011
    ..We conducted an intensification study to assess whether residual viral replication contributes to replenishment of the latent reservoir and whether mucosal HIV-specific T cell responses limit the reservoir size...
  11. ncbi request reprint Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia
    Annika C Karlsson
    Gladstone Institute of Virology and Immunology, University of California, San Francisco, USA
    AIDS 18:981-9. 2004
    ..The interaction of these factors is not well understood, particularly in the setting of antiretroviral therapy...
  12. pmc Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons
    Andy I Choi
    Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Clin Infect Dis 52:941-4. 2011
    ..If confirmed, these findings support a clinical trial of vitamin D supplementation to reduce cardiovascular events in HIV-infected persons...
  13. pmc HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers
    Peter W Hunt
    Department of Medicine, University of California, San Francisco, California, USA
    Clin Infect Dis 52:681-7. 2011
    ..Despite robust immune responses, these individuals never eradicate HIV infection. We hypothesized that HIV-specific CD4(+) T cells might serve as target cells for HIV, contributing to viral persistence in this setting...
  14. doi request reprint Cerebrospinal fluid in HIV-1 systemic viral controllers: absence of HIV-1 RNA and intrathecal inflammation
    John C Probasco
    Department of Neurology, University of California, San Francisco, San Francisco, California, USA
    AIDS 24:1001-5. 2010
    ..In this group, host-mediated viral control may be accompanied by chronic systemic inflammation. It is unknown whether either infection or chronic inflammation is present within the central nervous system of these individuals...
  15. pmc Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy
    Hiroyu Hatano
    San Francisco General Hospital, Building 80, Ward 84, 995 Potrero Avenue, San Francisco, CA 94110, USA
    J Virol 83:329-35. 2009
    ..This confirms the failure to eradicate the virus, even in these unique individuals who are able to reduce plasma viremia to very low levels without antiretroviral therapy...
  16. ncbi request reprint Changes in food insecurity, nutritional status, and physical health status after antiretroviral therapy initiation in rural Uganda
    Sheri D Weiser
    Department of Medicine, Division of HIV AIDS, San Francisco General Hospital, University of California San Francisco, San Francisco, CA 94110, USA
    J Acquir Immune Defic Syndr 61:179-86. 2012
    ..To investigate whether time on antiretroviral therapy (ART) is associated with improvements in food security and nutritional status, and the extent to which associations are mediated by improved physical health status...
  17. pmc Impact of HIV infection on diastolic function and left ventricular mass
    Priscilla Y Hsue
    Division of Cardiology, San Francisco General Hospital, San Francisco, CA 94110, USA
    Circ Heart Fail 3:132-9. 2010
    ..After adjustment for age and traditional risk factors, patients with HIV had a 2.4 greater odds of having diastolic dysfunction as compared with controls (P=0.019)...
  18. pmc Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy
    Peter W Hunt
    Department of Medicine, University of California, San Francisco, USA
    AIDS 25:2123-31. 2011
    ..To assess whether T-cell activation independently predicts the extent of CD4(+) T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy (ART)...
  19. doi request reprint Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda
    Mark J Siedner
    aMassachusetts General Hospital, Center for Global Health, Boston, Massachusetts, USA bMbarara University of Science and Technology, Mbarara, Uganda cChester M Pierce MD Division of Global Psychiatry, Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA dUniversity of California, San Francisco, California, USA eRagon Institute of Massachusetts General Hospital MIT and Harvard, and Harvard Medical School, Boston, Massachusetts, USA
    AIDS 28:267-71. 2014
    ..We sought to measure the frequency and correlates of periods of transmission risk among individuals taking ART during multiple years of observation in rural, southwestern Uganda...
  20. doi request reprint Discordance Between Peripheral and Colonic Markers of Inflammation During Suppressive ART
    Richard M Dunham
    HIV Discovery Performance Unit, GlaxoSmithKline, Research Triangle Park, NC Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, San Francisco, CA P ng Loke is now with the Department of Microbiology, Division of Parasitology, New York University Medical Center, New York, NY Biomedical Sciences Graduate Program, University of California, San Francisco, San Francisco, CA Division of Infectious Diseases, Department of Medicine, University of California, San Francisco and San Francisco VA Medical Center, San Francisco, CA Division of Infectious Diseases and HIV Medicine, Department of Medicine, Case Western Reserve University, Cleveland, OH Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA and Positive Health Program, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA
    J Acquir Immune Defic Syndr 65:133-41. 2014
    ..In this study, we sought to understand whether such systemic inflammation is also associated with detectable signs of inflammation in biopsies from the rectosigmoid colon...
  21. pmc Sexual relationship power and depression among HIV-infected women in Rural Uganda
    Abigail M Hatcher
    Division of HIV AIDS, Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    PLoS ONE 7:e49821. 2012
    ..Low sexual relationship power also contributes to HIV risk, but there is limited understanding of how it relates to mental health among HIV-infected women...
  22. doi request reprint A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis
    Karim Sacre
    Division of Experimental Medicine, San Francisco General Hospital, University of California San Francisco, 94110, USA
    AIDS 26:805-14. 2012
    ....
  23. pmc Valganciclovir reduces T cell activation in HIV-infected individuals with incomplete CD4+ T cell recovery on antiretroviral therapy
    Peter W Hunt
    Department of Medicine, University of California, San Francisco, USA
    J Infect Dis 203:1474-83. 2011
    ..We hypothesized that asymptomatic cytomegalovirus (CMV) replication might contribute to immune activation in this setting...
  24. pmc Higher CD27(+)CD8(+) T Cells Percentages during Suppressive Antiretroviral Therapy Predict Greater Subsequent CD4(+) T Cell Recovery in Treated HIV Infection
    Lillian Seu
    Department of Bioengineering and Therapeutic Sciences, Department of Pharmacy, University of California San Francisco, San Francisco, California, United States of America Division of Experimental Medicine, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 8:e84091. 2013
    ..092 cells/ul/month, P = 0.028). In HIV-infected subjects starting suppressive ART, patients with the highest percentage of CD8(+) T cells expressing CD27 had the greatest rate of CD4(+) T cell recovery. ..
  25. doi request reprint Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda
    Sheri D Weiser
    aDivision of HIV AIDS, San Francisco General Hospital, University of California, San Francisco UCSF, San Francisco bDepartment of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California cDepartment of Health Promotion, Education, and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina dMassachusetts General Hospital Center for Global Health, Boston, Massachusetts, USA eMbarara University of Science and Technology Mbarara, Uganda fUnited Nations World Food Programme, Rome, Italy gDepartment of Epidemiology and Biostatistics, UCSF, San Francisco, California hRagon Institute of MGH, MIT and Harvard University iDepartment of Global Health and Social Equity, Harvard Medical School jDepartment of Global Health and Populations, Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS 28:115-20. 2014
    ..We undertook a longitudinal study in rural Uganda to estimate the associations between food insecurity and HIV treatment outcomes...
  26. ncbi request reprint Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
    Peter W Hunt
    Positive Health Program, San Francisco General Hospital, University of California, San Francisco, California, USA
    AIDS 17:1907-15. 2003
    ..To determine the extent to which HIV-infected patients, including those with advanced immunodeficiency, can reverse peripheral CD4 T-cell depletion while maintaining long-term viral suppression on highly active antiretroviral therapy...
  27. pmc The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial
    Peter W Hunt
    Department of Medicine, University of California, San Francisco, San Francisco, CA 94110, USA
    Blood 121:4635-46. 2013
    ..These results may have relevance for trials of maraviroc for HIV preexposure prophylaxis and graft-versus-host disease. This trial was registered at www.clinicaltrials.gov as #NCT00735072...
  28. pmc Food insecurity is associated with morbidity and patterns of healthcare utilization among HIV-infected individuals in a resource-poor setting
    Sheri D Weiser
    Division of HIV AIDS, San Francisco General Hospital, University of California, San Francisco, 94143, USA
    AIDS 26:67-75. 2012
    ..We undertook a longitudinal study in rural Uganda to understand the association of food insecurity with morbidity and patterns of healthcare utilization among HIV-infected individuals enrolled in an antiretroviral therapy program...
  29. pmc Th17, gut, and HIV: therapeutic implications
    Peter W Hunt
    Positive Health Program, San Francisco General Hospital, University of California San Francisco, 995 Potrero Avenue, San Francisco, CA 94110, USA
    Curr Opin HIV AIDS 5:189-93. 2010
    ....
  30. pmc HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy
    Andy I Choi
    Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California 94121, USA
    AIDS 23:2143-9. 2009
    ..To identify risk factors associated with kidney function decline in a contemporary cohort of treated and untreated HIV-infected patients...
  31. ncbi request reprint Role of immune activation in HIV pathogenesis
    Peter W Hunt
    Positive Health Program, San Francisco General Hospital, Building 80, Ward 84, 995 Potrero Avenue, San Francisco, CA 94110, USA
    Curr HIV/AIDS Rep 4:42-7. 2007
    ....
  32. doi request reprint Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection
    Patrick Unemori
    Department of Dermatology, University of California, San Francisco, California 94110, USA
    AIDS 27:1735-42. 2013
    ..We investigated potential mechanisms for this phenomenon, focusing on measures of immune activation and T-cell senescence...
  33. doi request reprint Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers
    Hiroyu Hatano
    aDepartment of Medicine bDepartment of Epidemiology and Biostatistics, University of California cSan Francisco Veterans Affairs Medical Center, San Francisco, California, USA
    AIDS 27:2255-60. 2013
    ..HIV-infected controllers have provided novel insights into mechanisms of viral control. We investigated the degree to which HIV DNA and RNA are present in gut-associated lymphoid tissue (GALT) of controllers...
  34. pmc Immunologic basis of cardiovascular disease in HIV-infected adults
    Priscilla Y Hsue
    Division of Cardiology, Department of Medicine, San Francisco General Hospital, University of California San Francisco, 995 Potrero Ave, San Francisco, CA 94110, USA
    J Infect Dis 205:S375-82. 2012
    ....
  35. pmc Realtime adherence monitoring of antiretroviral therapy among hiv-infected adults and children in rural uganda
    Jessica E Haberer
    aMassachusetts General Hospital bHarvard Medical School, Boston cRagon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA dMbarara University of Science and Technology, Mbarara, Uganda eUniversity of California, San Francisco, California, USA
    AIDS 27:2166-8. 2013
    ..58 for each 10% increase), but not IVR/SMS. Wireless EAM creates an exciting opportunity to monitor and potentially intervene with adherence challenges as they are happening. ..
  36. pmc A simple LC-MS/MS method for determination of kynurenine and tryptophan concentrations in human plasma from HIV-infected patients
    Yong Huang
    Drug Studies Unit, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94143, USA
    Bioanalysis 5:1397-407. 2013
    ..In this article, we report a simple, rapid and specific LC-MS/MS method for accurate determination of Kyn and Trp concentrations in human plasma from HIV-infected patients...
  37. doi request reprint HIV and inflammation: mechanisms and consequences
    Peter W Hunt
    UCSF Positive Health Program, San Francisco, CA 94110, USA
    Curr HIV/AIDS Rep 9:139-47. 2012
    ..Other recent studies have helped clarify the roles of persistent HIV expression and/or replication, microbial translocation, and co-infections in driving this persistent inflammatory state, identifying targets for novel interventions...
  38. pmc Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009
    Elvin H Geng
    Department of Medicine, San Francisco General Hospital, University of California at San Francisco, 995 Potrero Avenue, San Francisco, CA, USA
    J Int AIDS Soc 14:46. 2011
    ..Regionally representative socio-demographic, laboratory and clinical characteristics of patients accessing ART over time and across sites have not been well described...
  39. pmc Tryptophan catabolism by indoleamine 2,3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease
    David Favre
    Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, CA 94110, USA
    Sci Transl Med 2:32ra36. 2010
    ..We postulate that induction of IDO may represent a critical initiating event that results in inversion of the T(H)17/T(reg) balance and in the consequent maintenance of a chronic inflammatory state in progressive HIV disease...
  40. pmc A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers
    Peter W Hunt
    Departments of Medicine and Laboratory Medicine, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 6:e15924. 2011
    ..These data support a model in which low frequencies of Tregs in HIV controllers may contribute to an effective adaptive immune response, but may also contribute to generalized immune activation, potentially contributing to CD4 depletion...
  41. doi request reprint Human leukocyte antigen B*57 does not fully explain hepatitis C clearance in HIV controllers
    Alice K Asher
    aDepartment of Community Health Systems, School of Nursing, University of California San Francisco bDepartment of Epidemiology and Biostatistics, University of California San Francisco cDepartment of Medicine, University of California San Francisco dBlood Systems Research Institute, San Francisco, California, USA
    AIDS 27:2691-6. 2013
    ..The objective of this study was to evaluate the role of human leukocyte antigen (HLA) B*57 and other genetic polymorphisms on HCV clearance in HIV controllers...
  42. doi request reprint HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods
    Lynn T Matthews
    aDivision of Infectious Disease, Massachusetts General Hospital, Center for Global Health bDivision of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts cSimon Fraser University, Faculty of Health Sciences, Burnaby, Canada dDepartment of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California eUniversity of British Columbia, School of Population and Public Health, Vancouver, Canada fMbarara University of Science and Technology, Mbarara, Uganda gDepartment of Medicine, Massachusetts General Hospital, Center for Global Health, Boston, Massachusetts hUniversity of California at San Francisco, Department of Medicine, San Francisco, California, USA
    AIDS 27:S105-12. 2013
    ..To assess the impact of pregnancy on mortality among HIV-infected Ugandan women initiating ART...
  43. pmc Lack of evidence for mtDNA as a biomarker of innate immune activation in HIV infection
    Adam S Lauring
    Department of Medicine, University of California San Francisco, San Francisco, California, United States of America alauring med umich edu
    PLoS ONE 7:e50486. 2012
    ..We did, however, observe a negative correlation between age and plasma mitochondrial DNA levels in individuals with well-controlled HIV...
  44. pmc Regional anthropometry changes in antiretroviral-naïve persons initiating a Zidovudine-containing regimen in Mbarara, Uganda
    Vanessa Thompson
    Department of Medicine, University of California, San Francisco, 94121, USA
    AIDS Res Hum Retroviruses 27:785-91. 2011
    ..Gains in the tricep skinfold, a reliable marker of subcutaneous fat, appeared blunted, which could indicate an inhibitory effect of zidovudine on peripheral subcutaneous fat recovery...
  45. doi request reprint The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapy
    Judith J Lok
    aHarvard School of Public Health bCenter for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts cSFGH HIV AIDS Division, University of California, San Francisco, California dUniversity of Washington School of Medicine, Seattle, Washington eUniversity of California, San Diego, California fDavid Geffen School of Medicine at UCLA and the Los Angeles Biomedical Institute of Research at Harbor UCLA, Los Angeles, California gUniversity of Rochester Medical Center, Rochester, New York hUniversity of California, San Francisco, California, USA
    AIDS 27:2101-10. 2013
    ..To assess whether CD8 T-cell activation predicts risk of AIDS and non-AIDS morbidity during suppressive antiretroviral treatment (ART)...
  46. doi request reprint Dysbiosis of the gut microbiota is associated with hiv disease progression and tryptophan catabolism
    Ivan Vujkovic-Cvijin
    Division of Experimental Medicine, Department of Medicine, University of California, San Francisco UCSF, San Francisco, CA 94110, USA
    Sci Transl Med 5:193ra91. 2013
    ..This link suggests that gut-resident microbial populations may influence intestinal homeostasis during HIV disease. ..
  47. ncbi request reprint Immune-based therapy for HIV infection: are acute and chronic HIV infection different diseases?
    Peter W Hunt
    J Infect Dis 194:1632-4. 2006